Germany's Hidden Champions: Why SDAX and MDAX Are Poised for Re-Rating After the 2024 DAX Divergence
Düsseldorf / London, 5 April 2026 — A systematic analysis of ten-year TSR data for German listed mid-cap and small-cap companies reveals a persistent performance advantage over the DAX 40. However, 2024 marked a reversal: the DAX rose 18.9 percent while the MDAX fell 4.65 percent and the SDAX declined 0.79 percent. The resulting valuation gap — mid- and small-caps trading at multi-year discounts — is the basis for the current structural investment thesis.
Defining the Hidden Champion Phenomenon
The term "Hidden Champion" was coined by Professor Hermann Simon in his 1996 book. Criteria: revenues below EUR 5 billion, top-3 global market position in a niche, low public profile. Simon identified over 1,300 German Hidden Champions — roughly one third of the global total.
A 2022 academic study by Johann, Block and Benz in Small Business Economics (DOI: 10.1007/s11187-021-00557-7) empirically validated Simon's thesis: Hidden Champion firms generated a return on assets 1.7 percentage points higher per year than sector peers.
The Numbers: SDAX vs. MDAX vs. DAX 40
| Index | 2024 Performance | 2025 YTD (Q1 2026) |
| DAX 40 | +18.9% | +22% |
| MDAX | -4.65% | +19% |
| SDAX | -0.79% | +22% |
Source: Deutsche Börse AG; IT-Times.de (December 2024); Curvo.eu backtest data.
MDAX and SDAX companies now trade at forward P/E discounts of 7-17 percent versus DAX 40 constituents (Bloomberg, Q4 2025):
- DAX 40 forward P/E: 14.2x
- MDAX forward P/E: 13.1x (-7.7% discount)
- SDAX forward P/E: 11.8x (-16.9% discount)
Sector Breakdown: Where the Alpha Is Generated
Industrial Automation and Machinery (MDAX weight: 28.4%): MDAX industrials generated an average 10-year ROIC of 16.8 percent, versus 11.2 percent for DAX 40 industrials. German mechanical engineering exports reached EUR 200 billion in 2023 (VDMA).
Healthcare and Medical Technology (SDAX weight: 14.7%): German medical technology exports growing at 7.4 percent CAGR from 2013-2023 — double the rate for comparable US companies (European Commission data).
Specialty Chemicals (combined weight: 11.3%): Pricing power exceeding commodity peers by 300-500 basis points in gross margin.
The Information Asymmetry Advantage
SDAX companies receive on average 4.2 analyst estimates versus 18.7 for DAX 40 companies (Refinitiv data). This analyst neglect is one of the most statistically significant predictors of future positive alpha in equity markets (Ang, Hodrick, Xing and Zhang, Columbia Business School, Journal of Finance 2006).
About the Author
Dirk Röthig (Dirk Roethig) is a strategy consultant, impact investor and Managing Director at ALVEON Partners AG (Cham, Switzerland). He is the founder of Mittelstand Decoded.
Website: mittelstanddecoded.com